Business Wire
Dexcom Appoints Rick Osterloh to Board of Directors
📈
AI Sentiment
Highly Positive
9/10
- Home
- DXCM
DXCM
DexCom Inc.
as of 02-27-2026 3:50pm EST
$73.69
$0.69
-0.93%
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 25.9B | IPO Year: | 2005 |
| Target Price: | $85.00 | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.09 | EPS Growth: | 47.18 |
| 52 Week Low/High: | $54.11 - $89.07 | Next Earning Date: | 05-07-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 14.46% | Revenue Growth (next year): | 12.39% |
| P/E Ratio: | 35.49 | Index: | |
| Free Cash Flow: | 1.1B | FCF Growth: | +70.79% |
AI-Powered DXCM Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 75.47%
75.47%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of DexCom Inc. (DXCM)
Heller Bridgette P
Sell
Director
DXCM Feb 12, 2026
Avg Cost/Share
$68.01
Shares
1,012
Total Value
$68,826.12
Owned After
26,019
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Heller Bridgette P | DXCM | Director | Feb 12, 2026 | Sell | $68.01 | 1,012 | $68,826.12 | 26,019 |
Latest DexCom Inc. News
DXCM Breaking Stock News: Dive into DXCM Ticker-Specific Updates for Smart Investing
Insider Monkey
Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership
âž–
AI Sentiment
Neutral
4/10
Simply Wall St.
DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat
📈
AI Sentiment
Highly Positive
9/10
Compare DXCM vs Leading Stocks
See how DXCM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DXCM DexCom Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.